Your browser is no longer supported. Please, upgrade your browser.
NVUS Novus Therapeutics, Inc. monthly Stock Chart
Novus Therapeutics, Inc.
Index- P/E- EPS (ttm)-3.94 Insider Own23.32% Shs Outstand6.69M Perf Week39.34%
Market Cap39.34M Forward P/E- EPS next Y-1.92 Insider Trans0.00% Shs Float4.89M Perf Month80.92%
Income-14.70M PEG- EPS next Q-0.38 Inst Own42.20% Short Float0.70% Perf Quarter41.35%
Sales- P/S- EPS this Y16.40% Inst Trans7.54% Short Ratio0.61 Perf Half Y25.91%
Book/sh2.97 P/B1.98 EPS next Y10.70% ROA-55.90% Target Price7.00 Perf Year-20.34%
Cash/sh- P/C- EPS next 5Y- ROE-62.50% 52W Range3.12 - 8.46 Perf YTD44.83%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-30.50% Beta0.65
Dividend %- Quick Ratio9.10 Sales past 5Y- Gross Margin- 52W Low88.46% ATR0.48
Employees8 Current Ratio9.10 Sales Q/Q- Oper. Margin- RSI (14)75.58 Volatility18.52% 9.82%
OptionableNo Debt/Eq0.00 EPS Q/Q88.40% Profit Margin- Rel Volume1.08 Prev Close6.19
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume55.89K Price5.88
Recom2.00 SMA2042.40% SMA5051.85% SMA20033.94% Volume60,462 Change-5.01%
Feb-13-18Initiated Ascendiant Capital Markets Buy $7
Jan-05-18 07:20PM  Should You Invest In The Healthcare Stock Novus Therapeutics Inc (NASDAQ:NVUS)? Simply Wall St.
Nov-21-17 03:00PM  Novus Therapeutics to Present at the 29th Annual Piper Jaffray Healthcare Conference PR Newswire
12:49PM  Who Are The Largest Shareholders In Novus Therapeutics Inc (NVUS)? Simply Wall St.
Nov-08-17 04:52PM  Novus Therapeutics Reports Third Quarter 2017 Results PR Newswire
Nov-06-17 04:01PM  Novus Therapeutics Announces the Promotion of Dr. Catherine Turkel to President PR Newswire -6.56%
Oct-05-17 09:26AM  Whats The Outlook For Loss-Making Novus Therapeutics Inc (NVUS)? Simply Wall St.
Aug-09-17 06:08PM  Novus Therapeutics Reports Second Quarter 2017 Results PR Newswire
Jul-10-17 06:30AM  Novus Therapeutics Announces Change in Management PR Newswire
Jun-12-17 08:00AM  Novus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
Otic Pharma Ltd. manufactures foam drug delivery system to treat ear disorders. The company was founded in 2008 and is based in Or-Yehuda, Israel.